Not admitted · Third-party claim
Rules 1.1.0 · as of 14 Sep 2026
Owen Scott Muir · Said 3 Mar 2026 · owen-2114
Quote
Third-party claim
“Early data suggest the strategies may converge on similar endpoints at the end of a full treatment course — but with an important caveat: the OFC approach seems to take longer to “kick in,” suggesting that if it’s going to be used, starting earlier in the course may matter.”
Leucter's ongoing open-label randomization at UCLA compares three augmentation strategies for early TMS non-responders (right OFC, right DLPFC, theta-burst priming of left DLPFC). Leucter's early read is that the strategies may end at similar endpoints.
A quoted or paraphrased claim by someone else that the author does not adopt as their own.